Painful; Hives; Feeling hot; Redness; Covid arm rash; Itchy; Hypersensitivity reaction first observed as itchy red spots on arm that woke the patient up; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction first observed as itchy red spots on arm that woke the patient up), PRURITUS (Itchy), PAIN (Painful), URTICARIA (Hives) and FEELING HOT (Feeling hot) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Anaphylaxis and Hives (Hives-Urticaria). Previously administered products included for Product used for unknown indication: Boostrix TDAP on 30-Mar-2021 and TDAP (Received in left bicep. Dose number 11 of 11) on 30-Mar-2021. Concurrent medical conditions included Allergic reaction to antibiotics (Throat began closing/suffocating) since 1987, Allergic reaction to bee sting (Swelling/hives. Patient carries an EpiPen now), Sulfonamide allergy (Hives/rash), Hypothyroidism since 2014, Blood pressure high since 2002, Raynaud's syndrome (Patient's left arm had less blood circulation) since 1988, Irritable bowel syndrome since 1980 and Allergy to insect sting (Swelling/hives. Patient carries an EpiPen now). Concomitant products included LEVOTHYROXINE, HYDROCHLOROTHIAZIDE, VITAMIN C [ASCORBIC ACID], LORATADINE and MONTELUKAST SODIUM for an unknown indication.    On 25-Mar-2021 at 9:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021 at 2:00 AM, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction first observed as itchy red spots on arm that woke the patient up). On an unknown date, the patient experienced PRURITUS (Itchy), PAIN (Painful), URTICARIA (Hives), FEELING HOT (Feeling hot), ERYTHEMA (Redness) and RASH (Covid arm rash). The patient was treated with CLOBETASOL PROPIONATE (CLOBETASOL 0.05%) from 06-Apr-2021 to 30-Apr-2021 for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 09-Apr-2021 at 9:00 AM, HYPERSENSITIVITY (Hypersensitivity reaction first observed as itchy red spots on arm that woke the patient up) had resolved. At the time of the report, PRURITUS (Itchy), PAIN (Painful), URTICARIA (Hives), FEELING HOT (Feeling hot), ERYTHEMA (Redness) and RASH (Covid arm rash) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient was not experiencing any acute illness at time of vaccination and up to one month before the vaccination.  The patient reported a painful, itchy rash eight days after the first vaccine in the right arm that lasted about eight days. The patient used Benadryl and Benadryl cream as well as ice frequently to alleviate some of the discomfort.  On 05-Apr-2021, the patient went to see a dermatologist and was prescribed Clobetasol 0.05 percent cream to treat it as Benadryl (both the oral and cream), and ice were not helping much.   This case was linked to MOD-2021-168749 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up information received on does not contain any new information. On 24-Jun-2021: Follow-up information was received on  contains information regarding the patient demographics, allergic conditions, concomitant medications and additional events hives, itching, Feeling hot, and hypersensitivity reaction. On 25-Jul-2021: Medical history was updated and causality for events were updated